| known also as: |
KIAA1484, LRFN1, Leucine-rich repeat and fibronectin type III domain-containing protein 1), leucine rich repeat and fibronectin type III domain containing 1, Anti-Synaptic adhesion-like molecule 2 (SALM2 |
| known also as: |
KIAA1484, LRFN1, Leucine-rich repeat and fibronectin type III domain-containing protein 1), leucine rich repeat and fibronectin type III domain containing 1, Synaptic adhesion-like molecule 2 (SALM2 |
| known also as: |
KIAA1484, LRFN1, Leucine-rich repeat and fibronectin type III domain-containing protein 1), leucine rich repeat and fibronectin type III domain containing 1, Synaptic adhesion-like molecule 2 (SALM2 |
| known also as: |
Synaptic adhesion-like molecule 2 |
| known also as: |
KIAA1484, LRFN1, Leucine-rich repeat and fibronectin type III domain-containing protein 1), leucine rich repeat and fibronectin type III domain containing 1, Anti -Synaptic adhesion-like molecule 2 (SALM2 |
| Other names: |
N/A, synaptic adhesion-like molecule 4 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Immunoglobulin isotype: |
IgG |
| Clone: |
Polyclonal antibody |
| Host organism: |
Source: Human, Host: Sheep |
| Species reactivity: |
Human |
| Specificity and cross-reactivity: |
Cross-reactivity, Recognizes human SALM2 |
| Purification method: |
Affinity Purified by immunoaffinity chromatography |
| Form/Appearance: |
5% trehalose, Reconstitute with sterile PBS, Supplied as a lyophilized powder in PBS |
| Storage and shipping: |
For maximum recovery of product, Further dilutions can be made in assay buffer, Reconstitute with sterile 40-50% glycerol, Reconstituted product is stable for 12 months productone should be stored at -20 degrees Celsius, aliquot and For optimal long term storage, centrifuge the original vial after thawing and prior to removing the cap, for short-term only, productone should be kept at -20 degrees Celsius, Lyophilized powder may be stored productone should be stored at -20 degrees Celsius |
| Tested for:: |
Western Blot (WB), ELISA (EL/EIA) |
| Description: |
KIAA1484, LRFN1, Leucine-rich repeat fibronectin type III domain-containing protein 1), leucine rich repeat fibronectin type III domain containing 1, cell adhesion molecules play a role in cell growth and activation and are often identified by WB or ELISA as in the Synaptic adhesion-like molecule 2 (SALM2 |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Gene target: |
KIAA1484, LRFN1, Leucine-rich repeat fibronectin III domain protein 1), leucine rich repeat fibronectin III domain 1, Synaptic adhesion-like molecule 2 (SALM2 |
| Short name: |
KIAA1484, LRFN1, Leucine-rich repeat fibronectin type III domain-containing protein 1), leucine rich repeat fibronectin type III domain containing 1, Synaptic adhesion-like molecule 2 (SALM2 |
| Alternative name: |
KIAA1484, LRFN1, Leucine-rich repeat and fibronectin classification III domain-containing protein 1), leucine rich repeat and fibronectin classification III domain containing 1, Synaptic adhesion-like molecule 2 (SALM2 |
| Identity: |
29290 |
| Gene: |
LRFN1 |
More about : LRFN1 |
| Long gene name: |
leucine rich repeat and fibronectin type III domain containing 1 |
| Synonyms: |
KIAA1484 SALM2 |
| Locus: |
19q13, 2 |
| Discovery year: |
2004-02-02 |
| GenBank acession: |
BC014678 |
| Entrez gene record: |
57622 |
| Pubmed identfication: |
10819331 16828986 |
| RefSeq identity: |
NM_020862 |
| Classification: |
I-set domain containing Fibronectin type III domain containing |
| Havana BLAST/BLAT: |
OTTHUMG00000182808 |